Alignment Healthcare, Inc. $ALHC Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. trimmed its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 2.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 823,158 shares of the company’s stock after selling 24,816 shares during the period. Charles Schwab Investment Management Inc. owned about 0.42% of Alignment Healthcare worth $15,327,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. MCF Advisors LLC lifted its position in Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after buying an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new position in Alignment Healthcare during the first quarter valued at approximately $42,000. Amalgamated Bank lifted its position in Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock valued at $65,000 after buying an additional 616 shares in the last quarter. Tower Research Capital LLC TRC lifted its position in Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after buying an additional 6,286 shares in the last quarter. Finally, Dark Forest Capital Management LP acquired a new position in shares of Alignment Healthcare during the fourth quarter worth $150,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently commented on ALHC shares. Zacks Research raised shares of Alignment Healthcare to a “hold” rating in a research report on Friday, August 8th. Stephens raised shares of Alignment Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. UBS Group boosted their target price on shares of Alignment Healthcare from $16.00 to $17.00 and gave the stock a “neutral” rating in a research report on Friday, May 2nd. Barclays raised shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $9.00 to $13.00 in a research report on Thursday, July 31st. Finally, Wall Street Zen cut shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $18.56.

Insiders Place Their Bets

In other news, CEO John E. Kao sold 180,000 shares of Alignment Healthcare stock in a transaction dated Thursday, July 10th. The shares were sold at an average price of $13.41, for a total value of $2,413,800.00. Following the completion of the transaction, the chief executive officer directly owned 1,553,100 shares of the company’s stock, valued at approximately $20,827,071. The trade was a 10.39% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Monday, July 14th. The shares were sold at an average price of $13.44, for a total transaction of $403,200.00. Following the completion of the transaction, the president directly owned 2,042,899 shares of the company’s stock, valued at $27,456,562.56. This trade represents a 1.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 624,153 shares of company stock worth $9,037,301. Corporate insiders own 7.00% of the company’s stock.

Alignment Healthcare Price Performance

Shares of ALHC stock opened at $15.84 on Friday. The firm has a market cap of $3.14 billion, a P/E ratio of -56.57 and a beta of 1.16. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66. Alignment Healthcare, Inc. has a 1-year low of $8.65 and a 1-year high of $21.06. The firm has a fifty day moving average of $13.77 and a two-hundred day moving average of $15.30.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $960.25 million. During the same period in the previous year, the business posted ($0.13) EPS. The company’s quarterly revenue was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.